Phase II study comparing radiochemotherapy with the FOLFOX 4 regimen versus radiochemotherapy with 5FU [fluorouracil]-cisplatin (Herskovic regimen) in first line treatment of patients with inoperable esophageal cancer

Trial Profile

Phase II study comparing radiochemotherapy with the FOLFOX 4 regimen versus radiochemotherapy with 5FU [fluorouracil]-cisplatin (Herskovic regimen) in first line treatment of patients with inoperable esophageal cancer

Completed
Phase of Trial: Phase II

Latest Information Update: 12 Oct 2010

At a glance

  • Drugs Cisplatin; Fluorouracil; Folinic acid; Oxaliplatin
  • Indications Oesophageal cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 12 Oct 2010 Results were presented in the British Journal of Cancer.
    • 01 Oct 2008 Actual number of patients enrolled was 97 was according to Clinicaltrials.gov record.
    • 18 Jul 2008 Status changed from in progress to completed, as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top